Skip to main content
logo
Neurizon Therapeutics Limited (ASX:NUZ)
Australia flag Australia · Delayed Price · Currency is AUD
0.0620
+0.0025 (4.20%)
Jul 31, 2026, 4:10 PM AEST

Neurizon Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
5.981.540.840.874.513.66
Revenue Growth
288.83%82.70%-3.66%-80.63%23.33%-11.24%
Gross Profit
5.981.540.840.874.23.43
Operating Income
-14.87-16.94-5.82-1.65-1.62-1.27
Net Income
-14.85-16.59-7.67-6.21-1.71-1.34
Earnings Per Share
-0.03-0.03-0.02-0.02-0.01-0.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
7.954.1810.732.722.423.02
Total Debt
1.62--1.051.391.28
Net Cash (Debt)
6.334.1810.731.671.031.75
Net Cash Growth
51.30%-61.03%541.45%61.66%-40.75%23.61%
Net Cash Per Share
0.010.010.030.010.000.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-17.45-14.29-5.17-1.56-1.33-0.94
Capital Expenditures
-0.01-0--0.03-0.04-0.1
Free Cash Flow
-17.46-14.29-5.17-1.6-1.38-1.04
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%93.03%93.84%
Operating Margin
-248.65%-1101.41%-691.08%-188.64%-35.92%-34.81%
Pretax Margin
-248.37%-1079.02%-1057.36%-179.95%-37.87%-36.57%
Profit Margin
-248.37%-1079.02%-911.61%-710.99%-37.88%-36.57%
FCF Margin
-291.97%-929.50%-614.05%-183.02%-30.50%-28.43%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
7.7451.22103.1029.834.927.88